1
|
Ho N, Tang K, Ngo V, Livits I, Morrel A, Noor B, Tseng K, Chung EJ. Nanoparticles-based technologies for cholera detection and therapy. SLAS Technol 2023; 28:384-392. [PMID: 37925157 DOI: 10.1016/j.slast.2023.10.006] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/26/2023] [Revised: 09/25/2023] [Accepted: 10/30/2023] [Indexed: 11/06/2023]
Abstract
Cholera is a waterborne disease caused by Vibrio cholerae bacteria generally transmitted through contaminated food or water sources. Although it has been eradicated in most Western countries, cholera continues to be a highly transmitted and lethal disease in several African and Southeast Asian countries. Unfortunately, current diagnostic methods for cholera have challenges including high cost or delayed diagnoses that can lead to increased disease transmission during pandemics, while current treatments such as therapeutic drugs and vaccines have limited efficacy against drug-resistant serogroups of Vibrio cholerae. As such, new solutions that can treat cholera in an efficient manner that avoids Vibrio cholerae's adaptive immunity are needed. Nanoparticles (NPs) are a suitable platform for enhancing current theranostic tools because of their biocompatibility and ability to improve drug circulation and targeting. Nanoparticle surfaces can also be modified with various protein receptors targeting cholera toxins produced by Vibrio cholerae. This review will address recent developments in diagnostics, therapeutics, and prevention against cholera particularly focusing on the use of metal-based nanoparticles and organic nanoparticles. We will then discuss future directions regarding nanoparticle research for cholera.
Collapse
Affiliation(s)
- Nathan Ho
- Department of Biomedical Engineering, University of Southern California, Los Angeles, CA 90089, United States
| | - Kaitlyn Tang
- Department of Biomedical Engineering, University of Southern California, Los Angeles, CA 90089, United States
| | - Vy Ngo
- Department of Biomedical Engineering, University of Southern California, Los Angeles, CA 90089, United States
| | - Isabella Livits
- Department of Biomedical Engineering, University of Southern California, Los Angeles, CA 90089, United States
| | - Alayne Morrel
- Department of Biomedical Engineering, University of Southern California, Los Angeles, CA 90089, United States
| | - Bari Noor
- Department of Biomedical Engineering, University of Southern California, Los Angeles, CA 90089, United States
| | - Kaylee Tseng
- Department of Biomedical Engineering, University of Southern California, Los Angeles, CA 90089, United States
| | - Eun Ji Chung
- Department of Biomedical Engineering, University of Southern California, Los Angeles, CA 90089, United States; Division of Vascular Surgery and Endovascular Therapy, Department of Surgery, Keck School of Medicine, University of Southern California, Los Angeles, CA 90033, United States; Mork Family Department of Chemical Engineering and Materials Science, University of Southern California, Los Angeles, CA 90089, United States; Eli and Edythe Broad Center for Regenerative Medicine and Stem Cell Research, Keck School of Medicine, University of Southern California, Los Angeles, CA 90033, United States; Division of Nephrology and Hypertension, Department of Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA 90033, United States; Norris Comprehensive Cancer Center, Keck School of Medicine, University of Southern California, Los Angeles, CA 90089, United States.
| |
Collapse
|